Amgen, Inc.
Registered Principal Details
Business Or Interest:
Pharmaceutical manufacturing
Lobbying Interests:
All matters relating to the pharmaceuticals and health care industries
CEO Name:
Robert Bradway
Executive Director
Pharmaceutical manufacturing
Lobbying Interests:
All matters relating to the pharmaceuticals and health care industries
CEO Name:
Robert Bradway
Executive Director
Contact
KS
Kathy Sherman
601 13th Street, NW, Suite 1100 North
Washington, DC 20005
(202) 585-9614
(202) 585-9729
kathy.sherman@amgen.com
601 13th Street, NW, Suite 1100 North
Washington, DC 20005
(202) 585-9614
(202) 585-9729
kathy.sherman@amgen.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| Kevin Johnson | Exclusive Duties No | Authorized On 12/17/2018 | Withdrawn On N/A |
| Matt Phillips | Exclusive Duties No | Authorized On 12/17/2018 | Withdrawn On 12/21/2018 |
| Scott Stenger | Exclusive Duties No | Authorized On 12/17/2018 | Withdrawn On 12/21/2018 |
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 24
Toggle details
Assembly Bill 24
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
Bill Text and History
4/5/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
Bill Text and History
For
Notification Date4/5/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 26
Toggle details
Senate Bill 26
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
Bill Text and History
2019 Wisconsin Act 12
4/5/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
Bill Text and History
2019 Wisconsin Act 12
For
Notification Date4/5/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Substitution of interchangeable biosimilars
Substitution of interchangeable biosimilars
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/14/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/14/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2019 January - June $894.24 |
2019 July - December $0.00 |
2020 January - June $0.00 |
2020 July - December $0.00 |
Total $894.24 |
| Total Hours Communicating | 2019 January - June 1.00 |
2019 July - December 0.00 |
2020 January - June 0.00 |
2020 July - December 0.00 |
Total 1.00 |
| Total Hours Other | 2019 January - June 11.00 |
2019 July - December 0.00 |
2020 January - June 0.00 |
2020 July - December 0.00 |
Total 11.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total |
|---|---|---|---|---|
| 2019 January - June 45% |
2019 July - December |
2020 January - June |
2020 July - December |
Total 42% |
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
| 2019 January - June |
2019 July - December |
2020 January - June |
2020 July - December |
Total |
|---|---|---|---|---|
| 2019 January - June 45% |
2019 July - December |
2020 January - June |
2020 July - December |
Total 42% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
No topics found.
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication